Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine with Hydrocortisone Enema for Ulcerative Colitis
NCT03110198Phase 4Unknown
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- May 2017
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ulcerative colitis (UC) comparing Mesalazine + Hydrocortisone, Mesalazine and Hydrocortisone (3 arms). Primary endpoint: Clinical Remission at 4 weeks. Status: unknown.
02
Drugs
Salcrozinehydrocortisone sodium succinate
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03110198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110198.